Evidence map›Paper›PMID 41405001›Full record

ArticleJournal of clinical pharmacology2026

Antibody Transfer From Mother to Fetus/Infant: An Opportunity for Model-Informed Precision Medicine.

Miramar Sami Kardouh, Tyler Dunlap, Rui Zhong, Jacqueline B Tiley, Yanguang Cao

Abstract read
In one paragraph

Article in Journal of clinical pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Miramar Sami KardouhDivision of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.ORCID https://orcid.org/0009-0003-0574-1270
Tyler DunlapDivision of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.ORCID https://orcid.org/0000-0003-0385-9219
Rui ZhongDivision of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.ORCID https://orcid.org/0000-0002-8936-6652
Jacqueline B TileyDivision of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Yanguang CaoDivision of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.ORCID https://orcid.org/0000-0002-3974-9073

Funding

UNC-Duke Collaborative Clinical Pharmacology Postdoctoral Training Program-Evaluation SupplementT32GM086330 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI KIM L.R. BROUWER, Daniel Gonzalez · 2011 to 2026
$8.5M
Integrated Transporter Elucidation CenterUC2HD113039 · NICHD · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · PI Lauren M Aleksunes, Dongeun Huh · 2023 to 2026
$4.5M
Quantitative Systems Pharmacology of Antibody Therapeutics across Diverse Biological ContextsR35GM152449 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Yanguang Cao · 2024 to 2026
$1.2M
NICHD NIH HHS UC2 HD113039NIGMS NIH HHS R35 GM152449NIGMS NIH HHS T32 GM086330NIH HHS R35 GM152449NIH HHS T32GM086330NIH HHS UC2HD113039
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

biologicsFcRnfetal exposurePBPKplacenta

Identifiers

PMID41405001
PMCPMC13501176

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.